12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Other News

Pharmstandard pharmaceuticals news

Pharmstandard said its board plans to spin off the company's branded OTC business. Pharmstandard reported 2012 net revenue of RUB12.7 billion ($416.6 million) from the OTC business, which represented 25% of Pharmstandard's 2012...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >